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THE prescription scripts written by general practitioners in Northern Ireland are
sent every month by pharmacists to the Pricing Bureau in Belfast so that pharma-
cists may be paid for the drugs and dressings they supply to patients. Since the
beginning of the National Health Service these prescriptions have been scrutinised
by the health authorities to determine the overall cost of the pharmaceutical services
and monitor the cost of each doctor's prescribing.
Since 1963, as a consequence of the thalidomide disaster, the details of all pre-
scriptions, recorded at first on Hollerith cards but since 1966 on a computer print-
out, have been made available to the Department of Therapeutics and Pharma-
cology of Queen's University on a confidential basis to aid in the detection of serious
adverse reactions to drugs and allow analysis of the use of drugs in the community.
The work carried out by the University Department has been entirely concerned
with the medical aspects of prescribing.
Initial studies by Professor Wade and Helen Hood (Wade and Hood, 1972a and
b) were of considerable interest. They showed that over the years individual doctors
are consistent in their prescribing habits both as to the drugs they prescribe and the
amount of prescribing they do. There are, however, very great differences between
doctors and strangely these differences are often found to have a geographical pat-
tern. For instance, practitioners in Newry prescribe more oral antidiabetic drugs for
their diabetic patients than do practitioners in Londonderry (Wade, Hadden and
Hood, 1973), and practitioners around Ballymena prescribe more antihypertensive
drugs than doctors around Enniskillen.
Since 1971, it has been possible with the help of the World Health Organisation
to extend these studies of drug use to Norway and Sweden. It has been found that
the levels of prescribing of certain groups of drugs are different in Northern Ireland
from Norway and different again from Sweden. As yet it has not been possible to
relate the prescribing of drugs in any of these countries to the incidence of disease
or to the therapeutic benefits that patients derive, but it is a real possibility that
further investigations may help to determine which patterns of prescribing and
which drugs are of most value in the community (Bergman, Elmes, Halse, Halvor-
sen, Hood, Lunde, Sj6qvist, Wade and Westerholm, 1975).
The patterns of prescribing change with time, because old doctors retire and are
replaced by new ones and because new drugs are introduced which replace or partly
replace old ones. The Department of Therapeutics now has complete records of
56prescribing in Northern Ireland since 1966, when the computer was first used in the
Pricing Bureau. It is proposed to describe and discuss the changes in prescribing
that have occurred over the first eight years of this survey in a series of short papers.
THE METHOD OF MEASUREMENT OF PRESCRIBING
In order to give the prescribing figures meaning, and to allow comparison with
other countries, the amounts of each drug prescribed is related to the population
size. To compare the prescribing of different drugs used for the same purpose, such
as the various diuretics or antibiotics, the amount is expressed in "agreed daily
doses" rather than in grams or milligrams because the dosage within a group of
similar drugs can differ widely. Occasionally, if a proprietary medicine contains a
mixture of two or more drugs, the agreed daily dose is expressed as one or more
tablets of the preparation. A list of "agreed daily doses" drawn up in collaboration
with colleagues in Norway and Sweden is given in the table and a full list is avail-
able in Drug Dose Statistics published by the Norwegian Drug Monopoly (Norsk
TABLE
Agreed daily doses for some commonly used preparations
APPROVED NAME COMMON PROPRIETARY AGREED DAILY
NAMES DOSE
Cardiac glycosides
Digoxin Lanoxin 0.25 mg
Digitoxin 0.1 mg
Tranquillisers and hypnotics
Chlordiazepoxide Librium 30 mg
Diazepam Valium 10mg
Nitrazopam Mogadon 5 mg
Methaqualone and diphenhydramine Mandrax 1 tablet
Antidiabetic drugs
Insulin 40 units
Chlorpropamide Diabinese 0.375 G
Tolbutamide Rastinon 1.5 G
Metformin Glucophage 2 G
Phenformin Dibotin 0.1 G
Antibiotics
Ampicillin Penbritin 2.0 G
Phenoxymethylpenicillin Penicillin V 1.5 m.IU
Hypotensives
Debrisoquine Declinax 30mg
Guanethidine Ismelin 30 mg
Methyldopa Aldomet 1 G
Reserpine Serpasil 0.5 G
Methoserpidine Decaserpyl 20 mg
Diuretics
Furosemide (=Frusemide) Lasix 40 mng
Chlorthalidone Hygroton 50 mg
Polythiazide Nephril 1 mg
57Medisinaldepot 1975). Thus the "agreed daily dose" of digoxin for a normal adult
for the purpose of these studies is 0.25 mgm. per day and for digitoxin is 0.1 mg.
per day. Of these two only digoxin is used in significant quantity in Northern Ire-
land. In the second quarter of 1974, 10.22 daily doses of digoxin were prescribed
per day per 1,000 patients on doctors' lists. This indicates that doctors prescribed
on average 2.55 mgm. of digoxin (10.22 doses of 0.25 mgm.) for every 1,000 patients
in their practice. It also means that if doctors are prescribing on the average 0.25 mg.
of digoxin a day for patients that need the drug, there are 10.22 patients in every
thousand of the population receiving digoxin. When comparing the use of drugs in
different practices, areas or countries, if the use of cardiac glycosides is found to
oe more than the average (10.22 daily doses per 1,000 patients per day), it suggests
either that there are more than the usual number of patients in that practice or area
with heart failure, that the criteria by which doctors recognise heart failure are
different, or that patients are receiving unusually large doses of cardiac glycosides.
In this last instance, it might be expected that in that practice or area, digitalis
intoxication might be a more frequent cause of admission to hospital than in other
areas.
One of the defects of this system is that prescribing of drugs by doctors may not
truely represent the consumption of drugs. Drugs supplied by pharmacists may not
be taken as instructed, may be left on the bathroom shelf for years deteriorating all
the time, or may be used, often inappropriately, by other members of the family.
The extent to which drugs are consumed as prescribed is known as the 'compliance'.
Studies in Northern Ireland, Norway and Birmingham are being started to measure
the compliance of patients to the wishes of doctors about drug taking, and these
studies should be of considerable help in estimating the true consumption of drugs
in the community.
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